Cancer cells are known for spreading genetic chaos. As cancer cells divide, DNA segments and even whole chromosomes can be duplicated, mutated, or lost altogether. This is called chromosomal instability, and scientists at Memorial Sloan Kettering have learned that it is associated with cancer's aggressiveness.
Gilead Advances Oncology Portfolio With New Data From Phase 3 ASCENT Trial of Trodelvy® in Metastatic Triple Negative Breast Cancer
SBLA Currently Under Review by the U.S. FDA for Full Marketing Approval in mTNBC Gilead Sciences, Inc. is presenting new data from the Phase 3 ASCENT trial of Trodelvy ® in metastatic triple-negative breast cancer at the 2020 San Antonio Breast Cancer Symposium being held virtually December 8-11, 2020. The new data and analyses from the ASCENT trial continue to demonstrate the high clinical activity of Trodelvy … sBLA Currently Under Review by the U.S. FDA for Full Marketing Approval in mTNBC Gilead Sciences, Inc. (Nasdaq: GILD) is presenting new data from the Phase 3 ASCENT trial of Trodelvy